Two Litigation Victories Honored Among California’s Top Verdicts for 2025
Daily Journal recognized a high‑profile securities class action and trade secret misappropriation wins as among the “largest and most impactful” of 2025.
Sarah Burack represents clients in complex commercial litigations and arbitrations and advises on pre-dispute communications and strategy.
Sarah leverages sophisticated technical knowledge and extensive experience to represent companies and individuals in disputes across multiple sectors, including:
She has successfully tried numerous cases to verdict in state and federal courts and in international and domestic arbitrations.
A recognized leader at the firm, Sarah sits on Latham’s Technology Committee and previously sat on the firm’s Associates Committee. She maintains an active pro bono practice focused on impact litigation and policy advice.
Sarah's recent experience includes representation of:
Daily Journal recognized a high‑profile securities class action and trade secret misappropriation wins as among the “largest and most impactful” of 2025.
California’s Daily Journal spotlights Latham team who won a landmark summary judgment victory for client Amgen in a securities class action.
Latham litigators honored after the Delaware Supreme Court upheld Latham’s motion to dismiss win for Edwards Lifesciences in a US$300 million earn-out dispute and for securing a major Ninth Circuit victory for global investment fund BC Partners.